Cosmo Pharmaceuticals N.V. (VIE:COPN)

Austria flag Austria · Delayed Price · Currency is EUR
115.00
+1.00 (0.88%)
At close: Jan 14, 2026
70.37%
Market Cap1.84B
Revenue (ttm)182.27M
Net Income (ttm)59.99M
Shares Outn/a
EPS (ttm)3.67
PE Ratio30.59
Forward PE393.55
Dividend2.05 (1.77%)
Ex-Dividend DateJun 4, 2025
Volumen/a
Average Volume3
Open113.00
Previous Close114.00
Day's Range113.00 - 115.00
52-Week Range44.80 - 118.00
Betan/a
RSI68.95
Earnings DateMar 9, 2026

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 322
Stock Exchange Vienna Stock Exchange
Ticker Symbol COPN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.